These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 23824794)
1. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794 [TBL] [Abstract][Full Text] [Related]
3. Let-7b is a novel regulator of hepatitis C virus replication. Cheng JC; Yeh YJ; Tseng CP; Hsu SD; Chang YL; Sakamoto N; Huang HD Cell Mol Life Sci; 2012 Aug; 69(15):2621-33. PubMed ID: 22391672 [TBL] [Abstract][Full Text] [Related]
4. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System. Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215 [TBL] [Abstract][Full Text] [Related]
5. Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection. Yeh YJ; Tseng CP; Hsu SD; Huang HY; Lai MMC; Huang HD; Cheng JC J Virol; 2021 Jan; 95(4):. PubMed ID: 33208444 [TBL] [Abstract][Full Text] [Related]
6. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Zhu H; Butera M; Nelson DR; Liu C Virol J; 2005 Sep; 2():80. PubMed ID: 16146571 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication. Chou WW; Huang CF; Yeh ML; Tsai YS; Hsieh MY; Huang CI; Huang JF; Tsai PC; Hsi E; Juo SH; Tsai WL; Chuang WL; Yu ML; Dai CY J Mol Med (Berl); 2016 Mar; 94(3):311-20. PubMed ID: 26489607 [TBL] [Abstract][Full Text] [Related]
8. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle. Kinast V; Plociennikowska A; Anggakusuma ; Bracht T; Todt D; Brown RJP; Boldanova T; Zhang Y; Brüggemann Y; Friesland M; Engelmann M; Vieyres G; Broering R; Vondran FWR; Heim MH; Sitek B; Bartenschlager R; Pietschmann T; Steinmann E J Hepatol; 2020 Sep; 73(3):549-558. PubMed ID: 32294532 [TBL] [Abstract][Full Text] [Related]
9. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex. Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway. Mukherjee A; Di Bisceglie AM; Ray RB J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644 [TBL] [Abstract][Full Text] [Related]
12. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Park H; Serti E; Eke O; Muchmore B; Prokunina-Olsson L; Capone S; Folgori A; Rehermann B Hepatology; 2012 Dec; 56(6):2060-70. PubMed ID: 22706965 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor. Liao TL; Chen YM; Hsieh SL; Tang KT; Chen DY; Yang YY; Liu HJ; Yang SS mBio; 2021 Dec; 12(6):e0276421. PubMed ID: 34724826 [TBL] [Abstract][Full Text] [Related]
14. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. Erickson AK; Seiwert S; Gale M Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919 [TBL] [Abstract][Full Text] [Related]
15. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture. Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178 [TBL] [Abstract][Full Text] [Related]
16. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. Castet V; Fournier C; Soulier A; Brillet R; Coste J; Larrey D; Dhumeaux D; Maurel P; Pawlotsky JM J Virol; 2002 Aug; 76(16):8189-99. PubMed ID: 12134024 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells. Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804 [TBL] [Abstract][Full Text] [Related]
18. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689 [TBL] [Abstract][Full Text] [Related]
19. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α. Zhang X; Daucher M; Armistead D; Russell R; Kottilil S PLoS One; 2013; 8(2):e55733. PubMed ID: 23418453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]